Polyimidazolium-based cationic antimicrobial polymers for novel mastitis prophylactic solutions
AssigneesNanyang Technological University, Massachusetts Institute of Technology
InventorsBee Eng Mary CHAN, Paula HAMMOND CUNNINGHAM, Kaixi ZHANG, Michelle Elizabeth FERGUSON
Life of this patent
Estimating the term…
Abstract
The present invention relates to a composition comprising a polyimidazolium (PIM) compound for use in the treatment and/or prevention of mastistis in a mammal, and to methods of use.
Claims21
A method of prophylaxis or treatment of mastitis in a mammal, comprising administering an efficacious amount of a composition comprising one or more polyimidazolium (PIM) compounds to said mammal, wherein the one or more polyimidazolium (PIM) compounds is selected from the group consisting of:
A composition comprising one or more polyimidazolium (PIM) compounds formulated to prevent or treat mastitis in a mammal, wherein said one or more polyimidazolium (PIM) compounds are selected from the group consisting of:
-23. (canceled)
Dependencies are inferred from the claim text.